SCHEMBL31170176

SCHEMBL31170176

N#Cc1c(N)sc2c(F)ccc(-c3c(Cl)cc4cnc(OC[C@@]56CCCN5C[C@H](F)C6)nc4c3F)c12

nearest known ligand 0.74

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 20/20 0.74
▸ MAPK3 P27361 1/20 0.40
▸ MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24717210 0.92 KRAS (0.62) KRAS
SCHEMBL31542459 0.90 KRAS (0.80) KRASMAPK3MAPK1
SCHEMBL25918465 0.90 KRAS (0.80) KRASMAPK3MAPK1
SCHEMBL30623536 0.89 KRAS (0.79) KRASMAPK3MAPK1
SCHEMBL25917865 0.89 KRAS (0.79) KRASMAPK3MAPK1
SCHEMBL27033778 0.89 KRAS (0.88) KRASMAPK3MAPK1
SCHEMBL25921391 0.89 KRAS (0.88) KRASMAPK3MAPK1
SCHEMBL31578616 0.88 KRAS (0.87) KRASMAPK3MAPK1
SCHEMBL25406046 0.88 KRAS (0.87) KRASMAPK3MAPK1
SCHEMBL30548069 0.88 KRAS (0.87) KRASMAPK3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4712961-A2 KRAS G12S AND G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2026-03-25 — — EP disclosed
WO-2024238633-A2 KRAS G12S AND G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2024-11-21 — — WO disclosed
Send feedback